CanScanPro™
CanScanPro™ represents a significant advancement in oncology, utilizing liquid biopsy technology to detect cancer-associated signals from a simple blood draw. By identifying fragments of circulating tumor DNA (ctDNA) shed into the bloodstream, this test supports the identification of cancer at early stages when treatment is often more effective.
Order a TestWho Is CanScanPro™ For?
High Family Risk
Ideal for individuals with a high family risk or genetic predisposition to cancer.
Unclear Imaging
Beneficial for patients presenting with equivocal imaging findings or inconclusive symptoms.
Simpler Alternative
Unlike traditional whole-body MRI or CT scans, CanScanPro™ detects cancer-associated signals through a simple blood draw — no radiation, no imaging equipment required.
How Does CanScanPro™ Benefit Patients?
CanScanPro™ is a high-sensitivity assay designed to identify somatic mutations and molecular signals suggestive of malignancy.
Early Insights: May detect cancer-related signals before symptoms appear.
Convenient & Safe: Unlike traditional biopsies, this requires only a standard blood draw, making it non-invasive and easy to repeat.
Precision Monitoring: Serves as a powerful complementary tool for longitudinal surveillance.
Actionable Results: If a signal is detected, it guides your doctor to recommend targeted additional diagnostic tests.
Clinical Utility & Implementation Tips
Complementary Positioning: This assay should supplement—not replace—standard screening tools like imaging or pathology.
Surveillance Integration: Incorporate the test into existing oncology protocols for high-risk individuals.
Referral Pathways: Establish a clear clinical pathway for immediate diagnostic follow-up if a “Detected” (positive) signal is returned.
Provider Education: Note that sensitivity may vary based on tumor type, stage, and the specific ctDNA shedding rate.
How It Works
A simple, guided process from consultation to clinically actionable reporting.
Ready to Integrate CanScanPro™ Into Your Practice?
Contact our team to learn how our tests can enhance your clinical offerings and improve patient outcomes.
Contact Sales Request Information